Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
This recent regulatory update is a game-changer and a massive catalyst for the marijuana industry.


The marijuana industry is finally experiencing a reprieve after years of underperformance following the 2018 "Weed Stock Mania." On October 6th, 2022, President Biden announced major reforms, which included:
Marijuana stocks and ETFs soared on the news. For example, the AdvisorShares Pure U.S. Cannabis ETF (MSOS) jumped nearly 40% intra-day as its underlying holdings surged. Other marijuana ETFs also saw strong inflows, signaling high amounts of investor interest.
Access Trackinsight's reliable and comprehensive data with 500M+ points on 14,000+ ETFs.
Jason Wilson, Cannabis Banking Expert at ETFMG was of the opinion that the recent announcement was merely the beginning of a long-awaited and extensive cannabis reform process. Wilson told me:
"Although President Biden did not go as far as Germany recently has by announcing that they will table draft legalization legislation by the end of the year, the President’s acknowledgment that it is time to right the wrongs of the federal government’s failed approach to marijuana, combined with his instructions to the Secretary of Health and Human Sciences and the Attorney General to expeditiously review marijuana’s classification under federal laws, provide a strong and important political statement suggesting that long-awaited cannabis reform may arrive sooner than expected."
This is a highly bullish sentiment evidently shared and anticipated by the market for a long time ever since Biden's 2020 campaign promises. The surge in cannabis stocks was likely a result of the "surprise" from the sudden announcement of these reforms previously discounted as a more remote possibility.
What Wilson found particularly important was Biden's instructions to the Secretary of Health and Human Services and the Attorney General to expeditiously review marijuana’s status under federal law. Wilson noted that this action effectively commenced the process to reschedule or de-schedule cannabis altogether under the Controlled Substances Act, where it is currently classified as Schedule I, the same classification as the most dangerous substances like heroin and LSD.
That being said, Wilson does not anticipate Biden's actions alone having a short-term material impact on the cannabis industry. "The path to rescheduling or de-scheduling cannabis by way of executive action will be a long and bureaucratic process that will take some time to work through, but Biden's actions did add momentum," he says.
Investors interested in the marijuana industry can use a variety of ETFs to gain exposure. It's worth carefully examining each fund's construction, methodology, and strategy. Some things to note when conducting your analysis include:
Depending on your preferences for the above, the following ETFs might be suitable for expressing a long position in the marijuana industry:
Please note this article is for information purposes only and does not constitute investment advice.
Segments
See all
Latest ETF News
See all ETF newsMoneyShow Chart of the Day 3/9/2026: Tallying Up the Costs in Oil Markets


MoneyShow Chart of the Day 2/11/2026: Why THIS Indicator Could be a Key Tech Tell


MoneyShow Chart of the Day 2/2/2026: The Wildest Week in Metals Ever?


MoneyShow Chart of the Day 1/28/2026: The Greenback is on the Brink...Again


Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Asset TV
The ETF Show - US-Iran Conflict Sends Oil ETFs Soaring
Lance McGray, Managing Director and Head of ETF Product at Advisors Asset Management joins The ETF Show.

What’sTheFund
What's the Fund | Thrivent Small Cap Value ETF (Ticker: TSCV)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Small Cap Value ETF (TSCV).

What’sTheFund
What's the Fund | Thrivent Small-Mid Cap Equity ETF (Ticker: TSME)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Small-Mid Cap Equity ETF (TSME).

What’sTheFund
What's the Fund | Thrivent Mid Cap Value ETF (Ticker: TMVE)
Kyle Detullio, ETF Capital Markets Specialist at Thrivent Asset Management, joins Ethan Hertzfeld on the NYSE trading floor to discuss the Thrivent Mid Cap Value ETF (TMVE).

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
